Skip to main content

Cardinal Health Value Stock - Dividend - Research Selection

Cardinal Health

ISIN: US14149Y1082, WKN: 880206

Market price date: 06.07.2022
Market price: 52,64 USD


Cardinal Health Fundamental data and company key figures of the share

Annual reports in USD
Key figures 11-08-2021
Cash flow
Net operating cash flow 2.429.000.000
Capital Expenditures -400.000.000
Free cash flow 2.028.999.936
Balance sheet
Total Equity 1.794.000.000
Liabilities & Shareholders equity 44.453.000.000
Income statement
Net income 611.000.000
Eps (diluted) 2,080
Diluted shares outstanding 290.148.000
Net sales/revenue 162.467.000.000

Fundamental ratios calculated on: 06-07-2022

Ratios
Key figures 06-07-2022
Cash flow
P/C 6,29
   
P/FC 7,53
Balance sheet
ROI1,37
ROE4,04
Income statement
P/E25,31
Div. Yield3,70%
P/B8,51
P/S0,09


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolCAH
Market Capitalization15.273.391.104,00 USD
CountryUnited States
IndicesS&P 500,MSCI World Index
SectorsHealth Care Distributors
Raw Data SourceUS GAAP in Millionen USD
Stock Split2001-04-24,3.0000/2.0000; 2001-04-23,3.0000/2.0000; 1998-11-03,3.0000/2.0000; 1998-11-02,3.0000/2.0000; 1996-12-18,3.0000/2.0000; 1996-12-17,3.0000/2.0000; 1994-07-02,5.0000/4.0000; 1994-07-01,5.0000/4.0000; 1991-10-02,5.0000/4.0000; 1991-10-01,5.0000/4.0000; 1990-10-02,5.0000/4.0000; 1990-10-01,5.0000/4.0000; 1989-10-03,5.0000/4.0000; 1989-10-02,5.0000/4.0000; 1988-09-10,11.0000/10.0000; 1988-09-09,11.0000/10.0000; 1987-09-10,11.0000/10.0000; 1987-09-09,11.0000/10.0000; 1986-02-25,100.0000/110.0000; 1985-03-26,100.0000/110.0000
Internetwww.cardinalhealth.com


Description of the company

Cardinal Health, Inc. is a healthcare services company providing products and services that help pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. During the fiscal year ended June 30, 2012 (fiscal 2012), the Company operated in two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, over-the-counter healthcare, and consumer products through its pharmaceutical distribution business to retailers. The Medical segment distributes a range of medical, surgical and laboratory products to hospitals, surgery centers, laboratories, physician offices and other healthcare providers. Effective March 18, 2013, it merged with AssuraMed Holding Inc.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.cardinalhealth.com


NEWS


Cardinal Health acquires the Bendcare CPO-GPO entity and makes a minority investment in the Bendcare MSO

2022-07-06
Cardinal Health (NYSE: CAH) announced today that it has acquired the Bendcare group purchasing organization (CPO-GPO) entity and made a minority investment in the Bendcare management services organization (MSO). Following the acquisition of the CPO-GPO, current Bendcare-affiliated CPO-GPO members will transition to Cardinal Health's Cornerstone Rheumatology™ GPO, and Cardinal Health will be the exclusive distributor for those practices.

Cardinal Health acquires the Bendcare CPO-GPO entity

2022-07-06
Cardinal Health announced... CAH

What's News : Business & Finance

2022-07-06
Slowing demand and recession fears helped bring the benchmark U.S. oil price below $100 a barrel Tuesday, continuing a rapid turnaround from soaring levels in recent months. SAS filed for... | July 6, 2022

'Minions' vs. 'Lightyear:' Here's why the silly yellow blobs beat Buzz at the box office

2022-07-05
'Minions' and 'Toy Story' are among the most popular and profitable franchises for their respective studios — so why did "Minions" soar and "Lightyear" flop?

McKesson, AmerisourceBergen and Cardinal Health Not Liable for Opioid Crisis in West Virginia, Court Rules

2022-07-05
A federal judge found that the plaintiffs, Cabell County and the city of Huntington, didn’t show that actions by McKesson, AmerisourceBergen and Cardinal Health caused the crisis.

Federal Judge Says McKesson, AmerisourceBergen, Cardinal Health Not Responsible For Opioid Epidemic: Report

2022-07-05
Federal judge David Faber rejected the efforts to force McKesson Corp (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), and Cardinal Health Inc (NYSE: CAH) to pay $2.5 billion for the opioid crisis. The judge ruled that the drug distributors are not responsible for fueling an opioid epidemic in a part of West Virginia, Reuters reported. Faber said the companies did not cause any oversupply of opioids, saying doctors' "good faith" prescribing decisions drove the volume of painkillers they shipped

McKesson, Cardinal, AmerisourceBergen not liable for WV opioid crisis, WSJ says

2022-07-05
Federal U.S. District jud... MCK, CAH, ABC

Federal judge rules in favor of drug distributors in West Virginia opioid case

2022-07-05
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

UPDATE 3-U.S. drug distributors prevail in $2.5 bln West Virginia opioid case

2022-07-04
Major U.S. drug distributors McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc are not responsible for fueling an opioid epidemic in a part of West Virginia, a federal judge ruled on Monday. U.S. District Judge David Faber rejected efforts by the city of Huntington and Cabell County to force the country's three largest pharmaceutical distributors to pay $2.5 billion to address a drug crisis prompted by a flood of addictive pills in their region.

U.S. drug distributors prevail in $2.5 billion West Virginia opioid case

2022-07-04
McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc are not responsible for fueling an opioid epidemic in a part of West Virginia, a federal judge ruled on Monday.